Awarded

SUMINISTRO MEDICAMENTOS EXCLUSIVOS: SEBELIPASA ALFA (KANUMA) Y RAVULIZUMAB (ULTOMIRIS).

Track this recordFree account — get alerted when a contract here runs out.
Contract value
€447,017
Bids received
1
Published
12 Jan 2026
Awarded
28 Nov 2025
Contract start
28 Nov 2025
Contract end
29 Nov 2026estimated
Region
Madrid

More awards from this buyer